Discrepancies in Anvisa report fuel debate on Brazil reg reform
This article was originally published in Clinica
Executive Summary
Brazilian healthcare regulatory agency Anvisa is coming under political pressure to relinquish some of its powers, so that it can carry out its healthcare product oversight roles more effectively.